Large retrospective study suggests DOACs are safe, effective alternative to low-molecular-weight heparin in complex patient population
Case series links catastrophic outcomes to therapy initiation within 48 hours post-procedure
ACC/AHA panel also upgrades catheter ablation recommendations
Details released from the trial halted due to excessive thromboembolic events
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Large database analysis finds no rise in in-hospital mortality relative to younger patients
Investigators urge caution until more data accrue
Program wins gold ELSO award
1,000-patient prospective trial to start enrolling patients soon
Advertisement
Advertisement